The writer argues unapproved peptides can carry risks for users when testing and quality checks don't keep pace with rising demand.
Recap by typeshit. Full story at Newsweek on MSN.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
32:25
The channel walks through FDA inspection findings of mold at suppliers and what people taking GLP-1 medications should watch for.
A fresh warning points to more people ending up in hospital after taking peptides that aren't approved. Tap through for who issued it.
As Ozempic, Wegovy and Mounjaro spread in clinics, OncoDaily covers the growing research interest in how these drugs relate to cancer.
A new 'In Discussion With' episode featuring Sehar Shahid on the pace of weight loss with GLP-1 receptor agonists. Few details shared beyond the topic.
Loading…